Learn · Mechanisms & evidence

The Science of Urolithin A

Urolithin A is one of the most researched mitochondrial nutrients in longevity science — studied for mitophagy activation, muscle energetics, and biomarkers of cellular aging.

Mechanism: from compound to mitochondria

  1. Intake: You take a defined dose of Urolithin A (Everas: 500 mg per serving).
  2. Absorption: The compound enters circulation and reaches tissues with high energy demand, including skeletal muscle.
  3. Mitophagy signaling: Urolithin A has been shown to support pathways involved in selective mitochondrial recycling.
  4. Renewal: Clearing dysfunctional mitochondria makes room for healthier mitochondrial populations and cleaner energy output.

What the research tradition focuses on

Peer-reviewed work on Urolithin A has explored areas such as:

  • Mitochondrial gene expression and mitophagy-related biomarkers
  • Muscle endurance and strength-related outcomes in adult populations
  • Cellular aging markers tied to mitochondrial function
  • Safety and tolerability of oral Urolithin A supplementation

How Everas talks about science

We stick to structure/function language: supporting cellular energy, mitochondrial health, stamina, and recovery. We do not claim to diagnose, treat, cure, or prevent disease. When we say “clinically relevant dose,” we mean a daily amount in the range commonly used in human Urolithin A research — not a micro-dose sprinkled into candy.

Dose context for serious protocols

Food-derived Urolithin A production is unreliable. Supplement studies typically use substantial daily intakes. Everas standardizes at 500 mg per serving so your protocol is unambiguous:

  • 2 capsules = 1 serving = 500 mg Urolithin A
  • 30 servings per pouch
  • Designed for daily use over multi-month horizons

Why capsule format matters for science you can verify

High-dose actives are difficult to stabilize and verify in soft confection formats. Heat, moisture, and matrix interactions can interfere with both manufacturing and lab recovery of the active.

Capsules allow:

  • Precise fill weights
  • Lower thermal stress during production
  • Cleaner third-party assay workflows for potency COAs
  • Zero sugar and a simple excipient profile

That is the scientific and operational reason Everas relaunched around clinical capsules rather than forcing 500 mg into a gummy matrix.

How to evaluate any Urolithin A brand

  • Is the milligram dose per serving stated clearly?
  • Is manufacturing done in a cGMP facility?
  • Are batches third-party tested for identity/potency/contaminants?
  • Is the format compatible with verifying that dose?

Those questions matter more than packaging trends. Everas is built to answer them directly.

This content is for educational purposes and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement.